Article · 22 Sep 2026
Research articlePublished 3 May 2019
Synthesis, In Vitro Anticancer Evaluation, and In Silico Studies of New Thiazolo[3,2-A]Pyrimidin-5-One Derivatives
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The present study involves the development of certain thiazolo[3,2-a]pyrimidin-5-ones linked through an ethylene bridge to various amines. The newly synthesized compounds 4-6(a-c) were subjected to in vitro anticancer evaluation using NCI antitumor screening. The target compounds showed observed activity against Renal UO-31 cancer cell line with cell growth promotion 52.72%-64.52%. Assessment of toxicities, druglikeness, and drug score profiles are reported. Some of the synthesized compounds showed good docking scores with potential anticancer targets. In vitro anticancer evaluation, together with in silico studies, revealed that compounds 5c, 4a, and 4b could be considered as promising leads for further development of more potent anticancer agents.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Der Pharma Chemica.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharma Chemica
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ahmed R. Ali”
- BylineArticles whose byline prints “Eman R. El-Bendary”
- BylineArticles whose byline prints “Mariam A. Ghaly”
- BylineArticles whose byline prints “Ihsan A. Shehata”